IP Library › Granted Patent US 9,828,410
Granted Patent B2
US 9,828,410 · App. 15/063,461 · Granted Nov 28, 2017

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N

Inventors: Jean-Pierre Sommadossi (Boston, MA); Adel Moussa (Burlington, MA)
Assignee: Atea Pharmaceuticals, Inc.
C07H19/207C07H19/16C07H19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,828,410
App. No.
15/063,461
Granted
Nov 28, 2017
Kind
B2
Abstract

A compound of the structure: or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.

Claims (3)

1. A compound of the formula:

2. The compound of claim 1 of the formula

3. The compound of claim 1 of the formula

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2016
From: SOMMADOSSI, JOHN-PIERRE; MOUSSA, ADEL
To: ATEA PHARMACEUTICALS, INC.
Reel/Frame 037914/0725 →
Continuity (4)
Provisional Application 62129319 · Mar 6, 2015
Provisional Application 62253958 · Nov 11, 2015
Provisional Application 62276597 · Jan 8, 2016
Related Publication 20160257706A1 · Sep 8, 2016